Melhores Cancro do fígado estádio 2 Cancro do fígado estádio 2 em Israel - TOP-18 médicos

A Dra. Pelles Sharon é especialista em tratamentos complexos de cancro do fígado, incluindo técnicas avançadas como a terapia SIRT e a ressecção hepática no Sourasky Medical Center.

• Oncologista altamente respeitada com extensas contribuições para a investigação clínica
• Fornecer tratamentos inovadores, como a quimioterapia intraperitoneal hipertérmica (HIPEC)
• Especialista em quimioterapia para cancro do fígado e ablação por radiofrequência
• Oferecer cuidados abrangentes com opções de terapia dirigida e imunoterapia

O Prof. Merimsky lidera a Unidade de Oncologia de Tecidos Moles e Ósseos no Sourasky Medical Center – um dos principais hospitais de tratamento de câncer em Israel.

• Mais de 25 anos de especialização em casos oncológicos complexos
• Formação de subespecialidade (Fellowship) no Institut Gustave Roussy para o tratamento de sarcomas
• Vice-presidente do Comitê de Ética do hospital
• Publicar numerosos artigos sobre tumores ósseos e de tecidos moles
• Membro docente do grupo de Sarcoma da ESMO

Mais de 30 anos de experiência focada em cancros gastrointestinais. Dirige o Centro de Prevenção do Cancro no Centro Médico Sourasky (Ichilov).

• Especializado exclusivamente na prevenção, diagnóstico precoce e tratamento de tumores gastrointestinais
• Autor de mais de 300 artigos científicos publicados sobre oncologia gastrointestinal
• Trabalho de investigação realizado no NewYork-Presbyterian Center, nos EUA
• Formação especializada em gastroenterologia na Faculdade de Medicina Sackler da Universidade de Tel Aviv
• Membro de sociedades internacionais como a European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Lidera a Divisão de Oncologia Médica do Sourasky Medical Center – um dos principais hospitais de Israel. Possui experiência específica em Oncologia e Medicina Interna.

• Certificação médica com formação abrangente, incluindo unidades médicas do exército
• Cargo de liderança sênior supervisionando todos os protocolos de tratamento de câncer
• Licenciatura em medicina pela Universidade Ben Gurion do Negev
• Especialização em tratamentos sistêmicos contra o câncer e coordenação de terapias

O Dr. Greenberg, um dos principais especialistas na cirurgia de Whipple e em cirurgia abdominal minimamente invasiva, chefia o Departamento de Cirurgia Colorretal do Centro Médico Sourasky (Ichilov).

• Mais de 20 anos de experiência como cirurgião abdominal
• Realizar técnicas cirúrgicas abertas e minimamente invasivas
• Especialista em procedimentos complexos de pâncreas e fígado, como a cirurgia de Whipple
• Liderar um departamento cirúrgico especializado em um grande hospital

Mais de 28 anos de especialização em cirurgia de cancro do fígado – O Dr. Ben-haim está entre os melhores cirurgiões de cancro gastrointestinal de Israel no Sourasky Medical Center.

• Ser especialista na cirurgia de Whipple para casos complexos
• Focar-se exclusivamente em cancros do fígado, pâncreas e gastrointestinais
• Realizar intervenções avançadas para condições oncológicas

O Dr. Auala Hubert lidera o Centro de Cancro Gastrointestinal do Hadassah Medical Center, contando com 33 anos de experiência focada em oncologia.

• Especializar-se em Oncologia Médica e Radioterapia
• Chefe do Centro de Cancro Gastrointestinal no Hadassah
• Certificado em Oncologia e Radioterapia
• Membro da Sociedade de Oncologia Clínica de Israel
• Fluente em inglês e hebraico para pacientes internacionais

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

O Dr. Alexander Beny é um oncologista certificado com ampla formação em oncologia médica e radioterápica, especializado em cancro do fígado no Rambam Medical Center.

• Chefe do Serviço de Malignidades Gastrointestinais no Rambam Medical Center
• Formado em Itália e Israel com certificação pelo conselho europeu
• Especializado em abordagens de oncologia médica e radioterápica
• Lidera clínicas dedicadas de gastrointestinal e onco-ginecologia

A Dra. Zalmanova é especialista em radioterapia no Assuta Medical Center, focando em tratamentos de câncer de fígado.

• Radioterapeuta com experiência em câncer de fígado estágio 2
• Trabalhar no Assuta Medical Center, uma instituição de saúde líder
• Dedicar-se a planos de tratamento personalizados para cada paciente